|
I too think it is a worthwhile article for everyone to read--except those who are HER2+++ and who completed treatment without Herceptin and are currently NED.
For us it is just one more article that tells us that as a group we have significantly more recurrences than those HER2's who have had Herceptin as part of their chemo treatment.
Where is the "compassionate" guidance and leadership now from those oncologists whose advice we followed through the months of chemotherapy? Why do we have to have recurrence before they will discuss the option of Herceptin with us?
|